Loading...
Dendritic cell-based vaccines: barriers and opportunities
Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option. However, DC-based vaccines face sever...
Saved in:
| Published in: | Future Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4260651/ https://ncbi.nlm.nih.gov/pubmed/23130928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.12.125 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|